GENEVA, April 6 -- NEUMIRNA THERAPEUTICS APS (c/o Center for RNA Medicine, AAU CPH, A.C. MeyersVaenge 152450 Kobenhavn SV) filed a patent application (PCT/EP2025/077662) for "ANTIMIR-27B FOR TREATMENT OF PARKINSON'S DISEASE" on Sep 26, 2025. With publication no. WO/2026/068729, the details related to the patent application was published on Apr 02, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): RIVERA PONSATI, Lluis (Neumirna Therapeutics ApSc/o Center for RNA MedicineAAU CPH, A.C. Meyers Vaenge 152450 Kobenhavn SV), TERRA ERLER, Janine (Neumirna Therapeutics ApSc/o Center for RNA MedicineAA...